Entecavir Tablet, Film Coated
Product Images NDC 70771-1019

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Entecavir (NDC 70771-1019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5856a358 F588 4855 A329 Be4bcc173c4a 02

5856a358 F588 4855 A329 Be4bcc173c4a 02
Label for Entecavir Tablets, USP 0.5 mg, film-coated oral tablets. The package contains 30 tablets for prescription use only, manufactured by Zydus Lifesciences Limited. Instructions include pharmacist dispensing information and storage conditions. The label includes an NDC number and manufacturer details from Matoda, Ahmedabad, India.*
FDA Label Image

5856a358 F588 4855 A329 Be4bcc173c4a 03

5856a358 F588 4855 A329 Be4bcc173c4a 03
Label for Entecavir Tablets USP containing 1 mg per film-coated oral tablet. The label indicates a package of 30 tablets, prescription only, manufactured by Zydus Lifesciences Limited. It includes storage instructions, a pharmacist dispensing notice, and the manufacturer location in India. The label features a small image of a round, brown tablet imprinted with "921".*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.